.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Dr. Norm's is stocked at 494 licensed dispensaries across California, with the deepest coverage in Los Angeles, Sacramento, Long Beach, San Diego, and San Jose. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In July 2026, Dr. Norm's mix tilted toward Edible at 59.61% share with a -14.60% year-over-year change and a 0.13% month-over-month uptick, while Capsules expanded to 29.93% share on a 1,583.99% year-over-year surge and a 4.03% month-over-month increase; Vapor Pens held 10.46% share with 5.72% year-over-year growth but a -2.72% month-over-month decline. Average price rose 12.74% year over year to $13.97, and in California Edible the brand sits at rank 20, implying the brand’s overall 22.74% year-over-year sales growth is being powered by rapid penetration in Capsules while Edible stabilizes and Vapor Pens softens month to month.
The shift toward a nearly one-third share in Capsules alongside a -14.60% year-over-year contraction in Edible signals a repositioning from an Edible-centric portfolio toward wellness-adjacent formats with higher average prices (Capsules at $22.00 versus Edible at $11.15), which can lift revenue per unit as mix shifts. Holding rank 20 in California Edible while Capsules grow 4.03% month over month indicates the path to improved category standing may come from sustaining Capsule momentum and selectively defending Edible, implying Dr. Norm's should prioritize Capsule-led acquisition while using Vapor Pens’ -2.72% month-over-month signal to constrain inventory risk.
Competitive Landscape
Dr. Norm's ranks #20 in CA Edible in July 2026, down 4 positions year over year from #16 and down 1 rank from April 2026’s #19, while sitting 6 spots below its January 2025 peak at #14; meanwhile, Wyld held #1 with 2.20% YoY sales growth and Good Tide stayed at #5 with 22.07% YoY growth, indicating the top tier expanded faster than mid-pack brands like Dr. Norm's that slipped 1 rank quarter-on-quarter and 4 ranks YoY. The pattern implies Dr. Norm's is ceding rank to higher-growth leaders and needs either mix or distribution shifts to reverse a drift from #14 in January 2025 to #20 in July 2026.
Notable Products
Mango Madness Max Solventless Hash Gummy (100mg) posted the standout movement in July 2026 with a 29.9% month-over-month increase, climbing to rank 4, while Wicked Watermelon Hash Gummy (100mg) rose 22.6% at rank 3. Indica Max Tablets 20-Pack (1000mg) held rank 1 with a 6.9% lift, and Sativa Max Tablets 20-Pack (1000mg) advanced 10.9% at rank 7. With six of the top ten being Edible SKUs, the mix points to a pivot toward flavor-led edibles buoying mid-pack ranks as Capsules anchor the top slot, implying Dr. Norm's is leaning into edible momentum while keeping high-dose Capsules as a traffic driver.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
